Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. SillaJen, Inc.
  6. News
  7. Summary
    A215600   KR7215600008

SILLAJEN, INC.

(A215600)
End-of-day quote Korea Stock Exchange  -  2022-11-29
9680.00 KRW   -0.82%
10/13SillaJen Resumes Trading on Kosdaq
MT
09/21SillaJen Bags Licensing Right to Basilea Pharmaceutica's Oncology Drug
MT
01/19Kosdaq Delists Biotechnology Company SillaJen
MT
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SillaJen Bags Licensing Right to Basilea Pharmaceutica's Oncology Drug

09/21/2022 | 07:11am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BASILEA PHARMACEUTICA AG -0.80% 49.35 Delayed Quote.21.58%
SILLAJEN, INC. -0.82% 9680 End-of-day quote.-20.00%
All news about SILLAJEN, INC.
10/13SillaJen Resumes Trading on Kosdaq
MT
09/21SillaJen Bags Licensing Right to Basilea Pharmaceutica's Oncology Drug
MT
01/19Kosdaq Delists Biotechnology Company SillaJen
MT
2021An unknown buyer agreed to acquire a 5.1% stake in NeoImmuneTech, Inc. from SillaJen, I..
CI
2021SillaJen, Inc. announced that it has received KRW 40 billion in funding
CI
2021SillaJen, Inc. announced that it has received KRW 60 billion in funding from M2N Co.,Lt..
CI
2021SillaJen, Inc. announced that it expects to receive KRW 40 billion in funding
CI
2021SillaJen, Inc. announced that it expects to receive KRW 60 billion in funding from M2N ..
CI
2021M2N Co.,Ltd signed LOI to acquire SillaJen, Inc..
CI
2020SillaJen, Inc.(KOSDAQ:A215600) dropped from FTSE All-World Index
CI
More news
Financials
Sales 2021 254 M 0,19 M 0,19 M
Net income 2021 -16 006 M -12,2 M -12,2 M
Net cash 2021 104 B 79,3 M 79,3 M
P/E ratio 2021 -63,9x
Yield 2021 -
Capitalization 995 B 756 M 756 M
EV / Sales 2020 515x
EV / Sales 2021 4 479x
Nbr of Employees 49
Free-Float 69,5%
Chart SILLAJEN, INC.
Duration : Period :
SillaJen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SILLAJEN, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Eun-Sang Moon Chief Executive Officer & Director
Ji-Won Choi Head-Research Institute
Kyung-Mi Yang Director, VP, Head-R&D Strategy Planning
Byung-Ju Kim Independent Director
Seung-Ki Hong Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SILLAJEN, INC.-20.00%756
VERTEX PHARMACEUTICALS46.07%81 217
REGENERON PHARMACEUTICALS, INC.19.03%80 283
BIONTECH SE-34.26%40 589
WUXI APPTEC CO., LTD.-34.22%32 137
GENMAB A/S25.29%29 594